2024-11-012025-10-312025-10-31false08729455SUSSEX OSTEOPATHS LTD2026-03-2086900falseiso4217:GBPxbrli:pure087294552024-10-31087294552025-10-31087294552024-11-012025-10-31087294552023-10-31087294552024-10-31087294552023-11-012024-10-3108729455bus:SmallEntities2024-11-012025-10-3108729455bus:AuditExempt-NoAccountantsReport2024-11-012025-10-3108729455bus:FullAccounts2024-11-012025-10-3108729455bus:PrivateLimitedCompanyLtd2024-11-012025-10-3108729455core:WithinOneYear2025-10-3108729455core:AfterOneYear2025-10-3108729455core:WithinOneYear2024-10-3108729455core:AfterOneYear2024-10-3108729455core:ShareCapital2025-10-3108729455core:SharePremium2025-10-3108729455core:RevaluationReserve2025-10-3108729455core:OtherReservesSubtotal2025-10-3108729455core:RetainedEarningsAccumulatedLosses2025-10-3108729455core:ShareCapital2024-10-3108729455core:SharePremium2024-10-3108729455core:RevaluationReserve2024-10-3108729455core:OtherReservesSubtotal2024-10-3108729455core:RetainedEarningsAccumulatedLosses2024-10-3108729455core:LandBuildings2025-10-3108729455core:PlantMachinery2025-10-3108729455core:Vehicles2025-10-3108729455core:FurnitureFittings2025-10-3108729455core:OfficeEquipment2025-10-3108729455core:NetGoodwill2025-10-3108729455core:IntangibleAssetsOtherThanGoodwill2025-10-3108729455core:ListedExchangeTraded2025-10-3108729455core:UnlistedNon-exchangeTraded2025-10-3108729455core:LandBuildings2024-10-3108729455core:PlantMachinery2024-10-3108729455core:Vehicles2024-10-3108729455core:FurnitureFittings2024-10-3108729455core:OfficeEquipment2024-10-3108729455core:NetGoodwill2024-10-3108729455core:IntangibleAssetsOtherThanGoodwill2024-10-3108729455core:ListedExchangeTraded2024-10-3108729455core:UnlistedNon-exchangeTraded2024-10-3108729455core:LandBuildings2024-11-012025-10-3108729455core:PlantMachinery2024-11-012025-10-3108729455core:Vehicles2024-11-012025-10-3108729455core:FurnitureFittings2024-11-012025-10-3108729455core:OfficeEquipment2024-11-012025-10-3108729455core:NetGoodwill2024-11-012025-10-3108729455core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3108729455core:ListedExchangeTraded2024-11-012025-10-3108729455core:UnlistedNon-exchangeTraded2024-11-012025-10-3108729455core:MoreThanFiveYears2024-11-012025-10-3108729455core:Non-currentFinancialInstruments2025-10-3108729455core:Non-currentFinancialInstruments2024-10-3108729455dpl:CostSales2024-11-012025-10-3108729455dpl:DistributionCosts2024-11-012025-10-3108729455core:LandBuildings2024-11-012025-10-3108729455core:PlantMachinery2024-11-012025-10-3108729455core:Vehicles2024-11-012025-10-3108729455core:FurnitureFittings2024-11-012025-10-3108729455core:OfficeEquipment2024-11-012025-10-3108729455dpl:AdministrativeExpenses2024-11-012025-10-3108729455core:NetGoodwill2024-11-012025-10-3108729455core:IntangibleAssetsOtherThanGoodwill2024-11-012025-10-3108729455dpl:GroupUndertakings2024-11-012025-10-3108729455dpl:ParticipatingInterests2024-11-012025-10-3108729455dpl:GroupUndertakingscore:ListedExchangeTraded2024-11-012025-10-3108729455core:ListedExchangeTraded2024-11-012025-10-3108729455dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-11-012025-10-3108729455core:UnlistedNon-exchangeTraded2024-11-012025-10-3108729455dpl:CostSales2023-11-012024-10-3108729455dpl:DistributionCosts2023-11-012024-10-3108729455core:LandBuildings2023-11-012024-10-3108729455core:PlantMachinery2023-11-012024-10-3108729455core:Vehicles2023-11-012024-10-3108729455core:FurnitureFittings2023-11-012024-10-3108729455core:OfficeEquipment2023-11-012024-10-3108729455dpl:AdministrativeExpenses2023-11-012024-10-3108729455core:NetGoodwill2023-11-012024-10-3108729455core:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3108729455dpl:GroupUndertakings2023-11-012024-10-3108729455dpl:ParticipatingInterests2023-11-012024-10-3108729455dpl:GroupUndertakingscore:ListedExchangeTraded2023-11-012024-10-3108729455core:ListedExchangeTraded2023-11-012024-10-3108729455dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-11-012024-10-3108729455core:UnlistedNon-exchangeTraded2023-11-012024-10-3108729455core:NetGoodwill2025-10-3108729455core:IntangibleAssetsOtherThanGoodwill2025-10-3108729455core:LandBuildings2025-10-3108729455core:PlantMachinery2025-10-3108729455core:Vehicles2025-10-3108729455core:FurnitureFittings2025-10-3108729455core:OfficeEquipment2025-10-3108729455core:AfterOneYear2025-10-3108729455core:WithinOneYear2025-10-3108729455core:ListedExchangeTraded2025-10-3108729455core:UnlistedNon-exchangeTraded2025-10-3108729455core:ShareCapital2025-10-3108729455core:SharePremium2025-10-3108729455core:RevaluationReserve2025-10-3108729455core:OtherReservesSubtotal2025-10-3108729455core:RetainedEarningsAccumulatedLosses2025-10-3108729455core:NetGoodwill2024-10-3108729455core:IntangibleAssetsOtherThanGoodwill2024-10-3108729455core:LandBuildings2024-10-3108729455core:PlantMachinery2024-10-3108729455core:Vehicles2024-10-3108729455core:FurnitureFittings2024-10-3108729455core:OfficeEquipment2024-10-3108729455core:AfterOneYear2024-10-3108729455core:WithinOneYear2024-10-3108729455core:ListedExchangeTraded2024-10-3108729455core:UnlistedNon-exchangeTraded2024-10-3108729455core:ShareCapital2024-10-3108729455core:SharePremium2024-10-3108729455core:RevaluationReserve2024-10-3108729455core:OtherReservesSubtotal2024-10-3108729455core:RetainedEarningsAccumulatedLosses2024-10-3108729455core:NetGoodwill2023-10-3108729455core:IntangibleAssetsOtherThanGoodwill2023-10-3108729455core:LandBuildings2023-10-3108729455core:PlantMachinery2023-10-3108729455core:Vehicles2023-10-3108729455core:FurnitureFittings2023-10-3108729455core:OfficeEquipment2023-10-3108729455core:AfterOneYear2023-10-3108729455core:WithinOneYear2023-10-3108729455core:ListedExchangeTraded2023-10-3108729455core:UnlistedNon-exchangeTraded2023-10-3108729455core:ShareCapital2023-10-3108729455core:SharePremium2023-10-3108729455core:RevaluationReserve2023-10-3108729455core:OtherReservesSubtotal2023-10-3108729455core:RetainedEarningsAccumulatedLosses2023-10-3108729455core:AfterOneYear2024-11-012025-10-3108729455core:WithinOneYear2024-11-012025-10-3108729455core:Non-currentFinancialInstrumentscore:CostValuation2024-11-012025-10-3108729455core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-11-012025-10-3108729455core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-11-012025-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-11-012025-10-3108729455core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-11-012025-10-3108729455core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-11-012025-10-3108729455core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3108729455core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-11-012025-10-3108729455core:Non-currentFinancialInstrumentscore:CostValuation2025-10-3108729455core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-10-3108729455core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-10-3108729455core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-10-3108729455core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-10-3108729455core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-10-3108729455core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-10-3108729455core:Non-currentFinancialInstrumentscore:CostValuation2024-10-3108729455core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-10-3108729455core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-10-3108729455core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-10-3108729455core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-10-3108729455core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-10-3108729455core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-10-3108729455core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-10-3108729455bus:Director12024-11-012025-10-3108729455bus:Director22024-11-012025-10-3108729455core:FurnitureFittingsToolsEquipment2024-10-3108729455core:FurnitureFittingsToolsEquipment2024-11-012025-10-3108729455core:FurnitureFittingsToolsEquipment2025-10-31

SUSSEX OSTEOPATHS LTD

Registered Number
08729455
(England and Wales)

Unaudited Financial Statements for the Year ended
31 October 2025

SUSSEX OSTEOPATHS LTD
Company Information
for the year from 1 November 2024 to 31 October 2025

Directors

C A Gaterell
S L Gaterell

Registered Address

12a Marlborough Place
Brighton
BN1 1WN

Registered Number

08729455 (England and Wales)
SUSSEX OSTEOPATHS LTD
Balance Sheet as at
31 October 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets343,03544,790
43,03544,790
Current assets
Debtors43,0003,000
Cash at bank and on hand7,25016,676
10,25019,676
Creditors amounts falling due within one year5(21,786)(27,208)
Net current assets (liabilities)(11,536)(7,532)
Total assets less current liabilities31,49937,258
Creditors amounts falling due after one year6(3,150)(8,550)
Net assets28,34928,708
Capital and reserves
Called up share capital11
Profit and loss account28,34828,707
Shareholders' funds28,34928,708
The financial statements were approved and authorised for issue by the Board of Directors on 20 March 2026, and are signed on its behalf by:
C A Gaterell
Director
Registered Company No. 08729455
SUSSEX OSTEOPATHS LTD
Notes to the Financial Statements
for the year ended 31 October 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Fixtures and fittings25
Finance leases and hire purchase contracts
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Land & buildings

Fixtures & fittings

Total

£££
Cost or valuation
At 01 November 2435,58724,46360,050
Additions-569569
At 31 October 2535,58725,03260,619
Depreciation and impairment
At 01 November 24-15,26015,260
Charge for year-2,3242,324
At 31 October 25-17,58417,584
Net book value
At 31 October 2535,5877,44843,035
At 31 October 2435,5879,20344,790
4.Debtors: amounts due within one year

2025

2024

££
Other debtors3,0003,000
Total3,0003,000
5.Creditors: amounts due within one year

2025

2024

££
Taxation and social security19,99425,432
Other creditors784816
Accrued liabilities and deferred income1,008960
Total21,78627,208
6.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts3,1508,550
Total3,1508,550